Transfusion for post-partum haemorrhage: What's new in 2011?;Hémorragie du post-partum: Actualités dans la prise en charge transfusionnelle

Transfusion Clinique et Biologique

Volumn 18, Issue 2, 2011, Pages 129-132

  Bonnet, M P ^a,b,c,d   Tesniere A ^a,b   Mignon, A ^a,b  

^a Institut Cochin   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL TENON   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

Antifibrinolytics; Antifibrinolytiques; Fresh frozen plasma; H morragie du post partum; Plasma frais congel ; Post partum haemorrhage

Indexed keywords

BLOOD CLOTTING FACTOR 7; FRESH FROZEN PLASMA; TRANEXAMIC ACID;

BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; DRUG INDICATION; ERYTHROCYTE CONCENTRATE; HEMOGLOBIN DETERMINATION; HUMAN; HYSTERECTOMY; MATERNAL MORTALITY; MEDICAL DECISION MAKING; POSTPARTUM HEMORRHAGE; PRACTICE GUIDELINE; SHORT SURVEY;

ANTIFIBRINOLYTIC AGENTS; BLOOD TRANSFUSION; CESAREAN SECTION; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; ERYTHROCYTE TRANSFUSION; FACTOR VIIA; FEMALE; FORECASTING; FRANCE; HEMOSTATIC TECHNIQUES; HUMANS; MULTICENTER STUDIES AS TOPIC; PLASMA; POSTOPERATIVE HEMORRHAGE; POSTPARTUM HEMORRHAGE; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; TRANEXAMIC ACID;

EID: 79954631300     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2011.02.011     Document Type: Short Survey

References (16)

1. Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of post-partum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg 2010;110(5):1368-1373.
2. Goffinet F., Mercier F., Teyssier V., Pierre F., Dreyfus M., Mignon A., Carbonne B., et al. Post-partum haemorrhage: recommendations for clinical practice by the CNGOF (December 2004). Gynecol Obstet Fertil 2005, 33(4):268-274.
3. Rainaldi M.P., Tazzari P.L., Scagliarini G., Borghi B., Conte R. Blood salvage during caesarean section. Br J Anaesth 1998, 80(2):195-198.
4. Rebarber A., Lonser R., Jackson S., Copel J.A., Sipes S. The safety of intraoperative autologous blood collection and autotransfusion during cesarean section. Am J Obstet Gynecol 1998, 179(3 Pt 1):715-720.
5. Sullivan I., Faulds J., Ralph C. Contamination of salvaged maternal blood by amniotic fluid and fetal red cells during elective Caesarean section. Br J Anaesth 2008, 101(2):225-229.
6. Practice guidelines for perioperative blood transfusion adjuvant therapies: an updated report by the American society of anesthesiologists task force on perioperative blood transfusion and adjuvant therapies. Anesthesiology 2006, 105(1):198-208.
7. Holcomb J.B., Jenkins D., Rhee P., Johannigman J., Mahoney P., Mehta S., et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007, 62(2):307-310.
8. Borgman M.A., Spinella P.C., Perkins J.G., Grathwohl K.W., Repine T., Beekley A.C., et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007, 63(4):805-813.
9. Snyder C.W., Weinberg J.A., McGwin G., Melton S.M., George R.L., Reiff D.A., et al. The relationship of blood product ratio to mortality: survival benefit or survival bias?. J Trauma 2009, 66(2):358-362. [discussion 362-364].
10. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, et al. Management of bleeding following major trauma: an updated European guideline. Crit Care;14(2):R52.
11. Roback JD, Caldwell S, Carson J, Davenport R, Drew MJ, Eder A, et al. Evidence-based practice guidelines for plasma transfusion. Transfusion 2010;50(6):1227-1239.
12. Charbit B., Mandelbrot L., Samain E., Baron G., Haddaoui B., Keita H., et al. The decrease of fibrinogen is an early predictor of the severity of post-partum hemorrhage. J Thromb Haemost 2007, 5(2):266-273.
13. Fenger-Eriksen C., Lindberg-Larsen M., Christensen A.Q., Ingerslev J., Sorensen B. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth 2008, 101(6):769-773.
14. Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010;376(9734):23-32.
15. Gungorduk K, Yildirim G, Asicioglu O, Gungorduk OC, Sudolmus S, Ark C. Efficacy of intravenous tranexamic acid in reducing blood loss after elective Cesarean section: a prospective, randomized, double-blind, placebo-controlled study. Am J Perinatol 2010; [sous presse]. doi:10.1055/s-0030-1268238.
16. Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, et al. The use of recombinant activated FVII in post-partum hemorrhage. Clin Obstet Gynecol 2010;53(1):219-27.